Candriam SCA’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-337,398
| Closed | -$2.82M | – | 858 |
|
|
2021
Q4 | $2.82M | Hold |
337,398
| – | – | 0.02% | 478 |
|
|
2021
Q3 | $2.51M | Hold |
337,398
| – | – | 0.02% | 534 |
|
|
2021
Q2 | $2.29M | Buy |
337,398
+337,393
| +6,747,860% | +$2.29M | 0.02% | 561 |
|
|
2021
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 823 |
|
|
2020
Q4 | – | Sell |
-352,760
| Closed | -$2.88M | – | 855 |
|
|
2020
Q3 | $2.88M | Buy |
+352,760
| New | +$2.88M | 0.03% | 443 |
|
|
2018
Q3 | – | Sell |
-25,000
| Closed | -$192K | – | 852 |
|
|
2018
Q2 | $192K | Buy |
+25,000
| New | +$192K | ﹤0.01% | 760 |
|